193 related articles for article (PubMed ID: 20597362)
1. [Antiarrhythmic properties of afobazole and other 2-mercaptobensimidazole derivatives].
Turilova AI; Mozhaeva TIa
Eksp Klin Farmakol; 2010 May; 73(5):8-11. PubMed ID: 20597362
[TBL] [Abstract][Full Text] [Related]
2. [Search for new drugs with antiarrhythmic properties among derivatives of adamant-2-ylamides of alkylamidocarbonic acids].
Turilova AI; Avdiutina NI; Piatin BM; Grushevskaia LN; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2013; 76(8):20-3. PubMed ID: 24228484
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
[TBL] [Abstract][Full Text] [Related]
4. [ANTIARRHYTHMIC EFFECTS OF 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE HEMISUCCINATE IN COMPARISON TO MEXIDOL.].
Turilova AI; Gan'shina TS; Avdyunina NI; Pyatin BM; Mirzoyan RS
Eksp Klin Farmakol; 2016; 79(7):8-11. PubMed ID: 29782738
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effects of LR-A/113 a new calcium antagonistic drug.
Stella L; de Novellis V; Vacca C; Guarino A; Cantoni V; Fici F; Rossi F
Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):235-48. PubMed ID: 8884994
[TBL] [Abstract][Full Text] [Related]
6. On the mechanism of antifibrillatory effect of afobazole.
Kryzhanovskyi SA; Stolyaruck VN; Vititnova MB; Tsorin IB; Seredenin SB
Bull Exp Biol Med; 2010 Sep; 149(3):314-7. PubMed ID: 21246090
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the antiarrhythmic activity of L-, D-and DL-stereoisomers of potassium magnesium aspartate].
Spasov AA; Iezhitsa IN; Zhuravleva NV; Gurova NA; Sinolitskiĭ MK; Voronin SP
Eksp Klin Farmakol; 2007; 70(1):17-21. PubMed ID: 17402586
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
[TBL] [Abstract][Full Text] [Related]
9. [Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives].
Chichkanov GG; Tsorin IB; Kirsanova GIu; Berdiaev SIu; Turilova AI
Eksp Klin Farmakol; 1997; 60(5):35-9. PubMed ID: 9483403
[TBL] [Abstract][Full Text] [Related]
10. [Nonlinear nature of the antiarrhythmic effects of lidocain].
Moskalenko AV
Biofizika; 2009; 54(1):62-7. PubMed ID: 19334634
[TBL] [Abstract][Full Text] [Related]
11. [The anti-arrhythmia activity of quinazopyrine].
Stets VR; Beregovaia EG; Dunaev VV; Storozhuk BG; Favoritov VN; Stoliarchuk AA; Mazur AI
Farmakol Toksikol; 1990; 53(3):15-7. PubMed ID: 2387373
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine.
Bartosova L; Novak F; Bebarova M; Frydrych M; Brunclik V; Opatrilova R; Kolevska J; Mokry P; Kollar P; Strnadova V; Suchy P
Eur J Pharmacol; 2007 Dec; 575(1-3):127-33. PubMed ID: 17706639
[TBL] [Abstract][Full Text] [Related]
13. [Antiarrhythmic properties of the anticonvulsant drug benzonal].
Saratikov AS; Fateeva SN; Forshkova VK
Farmakol Toksikol; 1987; 50(6):42-4. PubMed ID: 3436422
[TBL] [Abstract][Full Text] [Related]
14. RSD1000: a novel antiarrhythmic agent with increased potency under acidic and high-potassium conditions.
Yong SL; Xu R; McLarnon JG; Zolotoy AB; Beatch GN; Walker MJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):236-44. PubMed ID: 10087010
[TBL] [Abstract][Full Text] [Related]
15. [Antifibrillatory effect of antiarrhythmic drugs of various classes under conditions of activation of the parasympathetic nervous system].
Kaverina NV; Chichkanov GG; Tsorin IB
Eksp Klin Farmakol; 2004; 67(6):30-1. PubMed ID: 15707011
[TBL] [Abstract][Full Text] [Related]
16. [The anti-arrhythmia properties of thymogen].
Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
[TBL] [Abstract][Full Text] [Related]
17. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between the chemical structure and the antiarrhythmic action of ethacizine and its analogs].
Turilova AI; Berdiaev SIu; Grishchenko AN; Senova ZP
Farmakol Toksikol; 1990; 53(6):20-1. PubMed ID: 2081560
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic effect of acute oxygen-ozone administration to rats.
Di Filippo C; Cervone C; Rossi C; di Ronza C; Marfella R; Capodanno P; Luongo C; Rossi F; D'Amico M
Eur J Pharmacol; 2010 Mar; 629(1-3):89-95. PubMed ID: 19958767
[TBL] [Abstract][Full Text] [Related]
20. [Anti-arrhythmia properties of marcaine].
Dzhaparidze MM; Berdiaev SIu; Darinskiĭ NV; Senova ZP; Liubushkina TE
Biull Eksp Biol Med; 1983 Sep; 96(9):64-7. PubMed ID: 6616058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
